How to Prepare Anaesthesia for FMGE 2026: High-Yield Topics and Strategy
By Dr. Utsav Bhattacherjee, MBBS, MBA · 26 August 2026 · 9 min read
Anaesthesia has a short, well-defined syllabus, and its highest-yield content — a foundational staging classification, drug mechanism categories, and a standardised risk assessment system — is genuinely learnable as a compact set of frameworks rather than open-ended clinical judgment.
FMGE Anaesthesia high yield topics
- Guedel’s stages of anesthesia — the four-stage classification and why Stage II is the most dangerous.
- Local anesthetics — mechanism, ester versus amide classification, and toxicity recognition.
- Muscle relaxants — depolarising versus non-depolarising agents and their distinct mechanisms.
- ASA physical status classification — the standardised preoperative risk framework.
- General anesthesia components — the triad of hypnosis, analgesia and muscle relaxation.
Guedel’s stages of anesthesia
| Stage | Name | What happens |
|---|---|---|
| I | Analgesia | Conscious, with some analgesia, from induction start to loss of consciousness |
| II | Excitement or delirium | Unconscious but with irregular breathing and active, unpredictable reflexes — risk of vomiting and laryngospasm |
| III | Surgical anesthesia | Regular respiration, progressive loss of reflexes; surgery is performed here |
| IV | Medullary paralysis | Respiratory and vasomotor centre depression — a medical emergency, must be avoided |
Stage II is the most dangerous because reflexes remain active but unpredictable while breathing is irregular — modern fast-acting IV induction agents move patients through this stage very quickly, which is exactly why rapid induction is preferred over slower inhalational methods for this specific safety reason, beyond just patient comfort.
Local anesthetics: mechanism and classification
Local anesthetics work by blocking voltage-gated sodium channels in nerve membranes, preventing the propagation of the action potential and therefore blocking pain signal transmission. They classify into two chemical groups based on the linkage in their structure: esters (procaine, chloroprocaine) and amides (lidocaine, bupivacaine, ropivacaine) — a distinction with real clinical relevance, since esters are metabolised by plasma cholinesterase and carry a higher allergic reaction risk (related to a metabolite, para-aminobenzoic acid), while amides are metabolised hepatically and have a lower allergy risk. A simple mnemonic device: amide names contain two letter i’s (lidocaine, bupivacaine), while ester names contain one (procaine) — useful for quickly sorting an unfamiliar drug name into the correct category.
Local anesthetic systemic toxicity
Local anesthetic systemic toxicity (LAST) occurs when excessive local anesthetic enters systemic circulation, and recognising its progression is a genuine safety skill as well as an exam topic. Early signs are typically neurological — perioral numbness, tinnitus and metallic taste, progressing to seizures with higher levels. More severe toxicity affects the cardiovascular system, causing arrhythmias and potentially cardiac arrest, particularly with bupivacaine, which has a narrower safety margin between its neurological and cardiac toxicity thresholds than some other local anesthetics. Lipid emulsion therapy is the specific, defining treatment for severe LAST, working by helping sequester the lipophilic local anesthetic away from cardiac tissue — a distinctive treatment worth knowing precisely, since it is specific to this toxicity rather than a generic resuscitation measure.
Muscle relaxants: depolarising vs non-depolarising
Succinylcholine is the classic depolarising muscle relaxant, working by persistently activating the acetylcholine receptor (causing initial fasciculations before paralysis), with a rapid onset and short duration that makes it useful for rapid sequence intubation — but it carries specific risks including hyperkalemia (particularly dangerous in burn or crush injury patients) and malignant hyperthermia in susceptible individuals. Non-depolarising agents (rocuronium, vecuronium, atracurium) work by competitively blocking the acetylcholine receptor without activating it, avoiding the initial fasciculation and the hyperkalemia risk, but generally have a slower onset than succinylcholine. Reversal of non-depolarising block is achieved with acetylcholinesterase inhibitors (like neostigmine, generally given with an anticholinergic to counter its side effects) or, for certain agents, a more targeted reversal agent — depolarising blockade, by contrast, is not reversed by these same agents.
The ASA physical status classification
| Class | Description |
|---|---|
| ASA I | A normal, healthy patient |
| ASA II | Mild systemic disease, without functional limitation |
| ASA III | Severe systemic disease, with functional limitation |
| ASA IV | Severe systemic disease that is a constant threat to life |
| ASA V | A moribund patient not expected to survive without the operation |
| ASA VI | A declared brain-dead patient whose organs are being removed for donation |
This classification is used to communicate perioperative risk in a standardised way, and questions typically test whether you can correctly classify a described patient based on their comorbidities and functional status, rather than requiring memorisation of the categories in isolation.
The anesthesia triad
Balanced general anesthesia is typically built from three separate components, each addressed by different drug classes rather than a single agent doing everything: hypnosis (loss of consciousness, from agents like propofol or inhalational anesthetics), analgesia (pain control, from opioids), and muscle relaxation (from the neuromuscular blocking agents discussed above). Understanding that modern anesthesia deliberately separates these three goals — rather than relying on a single deep dose of one agent — explains why a typical anesthesia plan involves multiple drug classes given together, each targeting one leg of the triad.
Inhalational anesthetics and the MAC concept
Minimum alveolar concentration (MAC) is the standard measure of inhalational anesthetic potency — specifically, the concentration at which 50% of patients do not move in response to a surgical incision. A lower MAC value means a more potent agent, since less of it is needed to achieve the same effect — a detail that trips up candidates who assume a higher number means a stronger drug, which is backwards for this particular measure. MAC is also affected by patient factors: it decreases with age, hypothermia and pregnancy, and increases with chronic alcohol use and hyperthermia — recognising these modifying factors is often what a MAC-related question is actually testing, beyond the base definition itself.
Spinal vs epidural anesthesia
Both are forms of neuraxial anesthesia, but they differ in technique, onset and clinical use in ways worth knowing precisely. Spinal anesthesia involves injecting local anesthetic directly into the cerebrospinal fluid within the subarachnoid space, producing a rapid, dense block with a relatively small drug dose — well suited to procedures with a defined, shorter duration. Epidural anesthesia involves injecting local anesthetic into the epidural space, outside the dura, producing a slower-onset block that can be continuously maintained via a catheter for longer procedures or extended pain control, such as labor analgesia. A key practical distinction: a spinal is generally a single-shot technique with rapid onset, while an epidural’s catheter-based approach allows titration and prolongation — which is exactly why epidurals are favoured for labor (where duration is unpredictable) while spinals are often preferred for shorter, defined procedures like cesarean delivery. A rarer but important complication worth knowing for both: post-dural puncture headache, from cerebrospinal fluid leakage through the puncture site, classically positional (worse sitting or standing, relieved lying flat) and more common after spinal techniques or an inadvertent dural puncture during an epidural attempt.
A smart study plan for FMGE Anaesthesia
- Learn Guedel’s stages as a foundational framework, even though modern IV induction moves through them quickly — the underlying physiology is still what is being tested.
- Build a clear mental model of the ester-versus-amide distinction, since it explains both allergy risk and metabolism pathway in one framework rather than requiring separate memorisation.
- Treat LAST recognition as a genuine safety skill, not just an exam topic — knowing the early neurological warning signs matters clinically.
- Practise classifying patients into ASA categories from brief clinical descriptions, since that is the applied form this topic is actually tested in.
- Keep the spinal-versus-epidural distinction anchored to clinical use case, not just technique — knowing why one is chosen over the other clarifies both far better than memorising the anatomy alone.
For the complete high-yield picture across every FMGE subject, see our FMGE high yield topics guide, and for how Anaesthesia fits into your overall timeline, our FMGE December 2026 preparation strategy covers the sequencing across subjects.
